Macroeconomics

Asthma

Adverse effect

Depression (economics)

Proportional hazards model

Psychiatry

Attention deficit hyperactivity disorder

Economics

Montelukast

Major depressive disorder

Psychology

Comorbidity

Internal medicine

Pharmacology

Confidence interval

Hazard ratio

Mood

Methylphenidate

Medicine

The Journal of Allergy and Clinical Immunology In Practice

<h3>Background</h3> There have been conflicting results from observational studies regarding the risk of psychiatric adverse events (PAEs) with montelukast use. <h3>Objective</h3> To determine whether there are associations of depressive disorders, self-harm, and suicide with use of montelukast compared with inhaled corticosteroid (ICS) use. <h3>Methods</h3> Using data from the Sentinel Distributed Database from January 1, 2000, to September 30, 2015, patients (n = 457,377) exposed to montelukast or ICS, aged 6 years and older with a diagnosis of asthma, were matched 1:1 on propensity scores. Hazard ratios (HRs) and 95% CIs were estimated for each study outcome overall and by age, sex, psychiatric history, and pre-/post-2008 labeling updates using Cox proportional hazards regression models. <h3>Results</h3> Exposure to montelukast was associated with a lower risk of treated outpatient depressive disorder (HR, 0.91; 95% CI, 0.89-0.93). No increased risks of inpatient depressive disorder (HR, 1.06; 95% CI, 0.90-1.24), self-harm (HR, 0.92; 95% CI, 0.69-1.21), or self-harm using a modified algorithm (HR, 0.81; 95% CI, 0.63-1.05) were observed with montelukast use compared with ICS use. Most PAEs occurred in the roughly one-third of patients having a past psychiatric history. <h3>Conclusions</h3> When compared with use of ICS, we did not find associations between montelukast use and hospitalizations for depression or self-harm events. Our findings should be interpreted considering the study's limitations. Psychiatric comorbidity was common, and most PAEs occurred in patients with a past psychiatric history.

Risk of Psychiatric Adverse Events Among Montelukast Users